@article{ab0851b9b29649f0bdfdb45d681839ec,
title = "EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers",
keywords = "atopic dermatitis, biologics, biomarkers",
author = "Bakker, \{Daphne S.\} and Ariens, \{Lieneke F.M.\} and Barbara Giovannone and Hijnen, \{Dirk Jan\} and Delemarre, \{Eveline M.\} and Edward Knol and Stefan Nierkens and \{de Bruin-Weller\}, \{Marjolein S.\} and Thijs, \{Judith L.\} and Julia Drylewicz",
note = "Funding Information: Dr Bakker reports personal fees from Sanofi Genzyme, outside the submitted work. Dr Hijnen reports grants and personal fees from AbbVie, personal fees from Eli Lilly, personal fees from Incyte, personal fees from Sanofi/Genzyme, grants from Thermo Fisher and personal fees from Pfizer, outside the submitted work. Dr de Bruin‐Weller reports grants as Advisory Board Member/consultant AbbVie, grants as Advisory Board Member/consultant Pfizer, grants as Advisory Board Member/consultant Sanofi Genzyme, grants as Advisory Board Member UCB, grants as Advisory Board Member/consultant Eli Lilly, grants as Advisory Board Member/consultant Regeneron, grants as Advisory Board Member Galderma, grants as PI multicenter studies AbbVie, grants as PI multicenter studies Pfizer, grants as PI multicenter studies Galderma, outside the submitted work. Dr Thijs reports personal fees from Sanofi Genzyme, outside the submitted work. All other authors have nothing to disclose.",
year = "2020",
month = dec,
doi = "10.1111/all.14492",
language = "English",
volume = "75",
pages = "3287--3289",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "12",
}